{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:37:38Z","timestamp":1793054258899,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012626","name":"Japan Allergy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012626","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.alit.2022.11.012","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T15:30:32Z","timestamp":1672327832000},"page":"402-410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Blood eosinophil count variability in chronic obstructive pulmonary disease and severe asthma"],"prefix":"10.1016","volume":"72","author":[{"given":"Yuki","family":"Abe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoruko","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomu","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Oguma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Machiko","family":"Matsumoto-Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houman","family":"Goudarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironi","family":"Makita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Konno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2022.11.012_bib1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jaip.2014.06.005","article-title":"High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma","volume":"2","author":"Zeiger","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2022.11.012_bib2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S2213-2600(16)30031-5","article-title":"Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies","volume":"4","author":"Ortega","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.alit.2022.11.012_bib3","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S2213-2600(16)00100-4","article-title":"Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial","volume":"4","author":"Watz","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.alit.2022.11.012_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/cea.13310","article-title":"Variability of blood eosinophils in patients in a clinic for severe asthma","volume":"49","author":"Rakowski","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2022.11.012_bib5","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.chest.2019.04.012","article-title":"Stability of the blood eosinophilic phenotype in stable and exacerbated COPD","volume":"156","author":"Schumann","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.alit.2022.11.012_bib6","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1513\/AnnalsATS.202010-1249OC","article-title":"A\u00a0Comprehensive analysis of the stability of blood eosinophil levels","volume":"18","author":"Chipps","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.alit.2022.11.012_bib7","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1164\/rccm.201602-0353OC","article-title":"Asthma-like features and clinical course of chronic obstructive pulmonary disease. An analysis from the Hokkaido COPD Cohort Study","volume":"194","author":"Suzuki","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2022.11.012_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1513\/AnnalsATS.201701-065OC","article-title":"Distinct phenotypes of smokers with fixed airflow limitation identified by cluster analysis of severe asthma","volume":"15","author":"Konno","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.alit.2022.11.012_bib9","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1046\/j.1365-2222.2003.01730.x","article-title":"Effects of asthma on cell components in peripheral blood among smokers and non-smokers","volume":"33","author":"Sunyer","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2022.11.012_bib10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2222.2011.03945.x","article-title":"Associated demographics of persistent exhaled nitric oxide elevation in treated asthmatics","volume":"42","author":"Matsunaga","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2022.11.012_bib11","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1378\/chest.120.6.1917","article-title":"Smoking and airway inflammation in patients with mild asthma","volume":"120","author":"Chalmers","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.alit.2022.11.012_bib12","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/j.1365-2222.2008.03032.x","article-title":"Influence of smoking on airway inflammation and remodelling in asthma","volume":"38","author":"St-Laurent","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2022.11.012_bib13","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/thx.2006.072777","article-title":"Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease","volume":"62","author":"Makita","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.alit.2022.11.012_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1164\/rccm.201106-0992OC","article-title":"Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease","volume":"185","author":"Nishimura","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2022.11.012_bib15","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1183\/09031936.00110213","article-title":"Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study","volume":"43","author":"Suzuki","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2022.11.012_bib16","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.2147\/COPD.S264437","article-title":"Unique mortality profile in Japanese patients with COPD: an analysis from the Hokkaido COPD Cohort Study","volume":"15","author":"Makita","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.alit.2022.11.012_bib17","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Updated 2022. Available at: https:\/\/goldcopd.org. [Accessed 1 June 2022]."},{"key":"10.1016\/j.alit.2022.11.012_bib18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1513\/AnnalsATS.201606-463OC","article-title":"Sinus computed tomographic findings in adult smokers and nonsmokers with asthma. Analysis of clinical indices and biomarkers","volume":"14","author":"Kimura","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.alit.2022.11.012_bib19","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/cea.13170","article-title":"Prospective predictors of exacerbation status in severe asthma over a 3-year follow-up","volume":"48","author":"Kimura","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2022.11.012_bib20","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jaci.2021.07.042","article-title":"Parenchymal destruction in asthma: fixed airflow obstruction and lung function trajectory","volume":"149","author":"Shimizu","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2022.11.012_bib21","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1164\/ajrccm.162.6.ats9-00","article-title":"Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions","volume":"162","year":"2000","journal-title":"Am Thorac Soc Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2022.11.012_bib22","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaci.2015.05.039","article-title":"Blood eosinophil counts predict treatment response in patients with severe eosinophilic asthma","volume":"136","author":"Ortega","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2022.11.012_bib23","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S2213-2600(15)00050-8","article-title":"Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis","volume":"3","author":"Korevaar","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.alit.2022.11.012_bib24","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an anti-interleukin-5 receptor \u03b1 monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2022.11.012_bib25","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.anai.2016.08.010","article-title":"Variability of blood eosinophil count as an asthma biomarker","volume":"117","author":"Mathur","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.alit.2022.11.012_bib26","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1164\/rccm.201502-0235LE","article-title":"Blood eosinophils: a biomarker of response to extrafine beclomethasone\/formoterol in chronic obstructive pulmonary disease","volume":"192","author":"Siddiqui","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2022.11.012_bib27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2213-2600(18)30006-7","article-title":"Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials","volume":"6","author":"Bafadhel","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.alit.2022.11.012_bib28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12890-020-01234-3","article-title":"The stability of blood eosinophils in stable chronic obstructive pulmonary disease: a retrospective study in Belgian primary care","volume":"20","author":"Van Rossem","year":"2020","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.alit.2022.11.012_bib29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaci.2017.12.1009","article-title":"Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids","volume":"143","author":"Peters","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2022.11.012_bib30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.rmed.2017.04.005","article-title":"Acute bronchodilator responses to beta2-agonist and anticholinergic agent in COPD: their different associations with exacerbation","volume":"127","author":"Konno","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.alit.2022.11.012_bib31","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"2 Suppl","key":"10.1016\/j.alit.2022.11.012_bib32","article-title":"One airway, one disease","volume":"111","author":"Grossman","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.alit.2022.11.012_bib33","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1046\/j.1365-2222.2000.00834.x","article-title":"Effect of pranlukast on bronchial inflammation in patients with asthma","volume":"30","author":"Yoshida","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2022.11.012_bib34","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1513\/AnnalsATS.202103-409OC","article-title":"Impact of blood eosinophil variability in asthma: a real-life population study","volume":"19","author":"Toledo-Pons","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.alit.2022.11.012_bib35","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.2147\/COPD.S165909","article-title":"Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort","volume":"13","author":"Greulich","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.alit.2022.11.012_bib36","doi-asserted-by":"crossref","first-page":"1702536","DOI":"10.1183\/13993003.02536-2017","article-title":"Associations between blood eosinophils and decline in lung function among adults with and without asthma","volume":"51","author":"Hancox","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2022.11.012_bib37","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12931-020-01460-7","article-title":"Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry","volume":"21","author":"Graff","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.alit.2022.11.012_bib38","doi-asserted-by":"crossref","first-page":"e000151","DOI":"10.1136\/bmjresp-2016-000151","article-title":"Effect of inhaled corticosteroids on blood eosinophil count in steroid-na\u00efve patients with COPD","volume":"3","author":"Kreindler","year":"2016","journal-title":"BMJ Open Respir Res"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893022001393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893022001393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:13:01Z","timestamp":1761156781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893022001393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1323893022001393"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2022.11.012","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood eosinophil count variability in chronic obstructive pulmonary disease and severe asthma","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2022.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese Society of Allergology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}